drugset / Trial / NCT00186316
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patients with Multiple myeloma who have undergone non-myeloablative allogeneic stem cell transplant will receive 6 vaccinations of donor derived dendritic cells combined with specific protein produced by multiple myeloma.
Timeline
- Start
- 2003-04
- Primary completion
- 2006-04
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Idiotype-pulsed allogeneic dendritic cells | Cell therapy | — | — |